Home / Safety / Kimi for pharmacy & pharmaceuticals

Moonshot AI

How safe is Kimi for pharmacy?

GDPR profileOur summary of what the provider itself publishes about your data: EU hosting possible, no training on your data for business use, and self-hostable. Caution is given to a model with a documented issue, such as an investigation by a regulator. How we measure for pharmacy & pharmaceuticalsCaution

Kimi has a specific GDPR concern. The parent company is based in Beijing and falls under Chinese security legislation; the privacy policy does not explicitly name that jurisdiction. Keep confidential data out of the consumer app; self-hosting the open weights is the safe route. Weigh this heavily before deploying it in pharmacy & pharmacology.

Where does Kimi stand in pharmacy & pharmaceuticals?

Shared spot 22 of 28 options for pharmacy & pharmaceuticals (professional tools and general assistants) on GDPR profile. 7 options, like Kimi, have a profile to watch. Each tile is an option we track for this field; click for the check.

Strong6
Good6
Limited6
Unknown3
Caution7

Stronger or equally strong in pharmacy & pharmaceuticals

Latest developments

26 July 2026Kimi K3 open weights (27 July): self-hosting avoids China transfer, licence still unclear

On 27 July 2026, Moonshot AI published the full open weights of Kimi K3 (2.8 trillion parameters, 1M-token context) on Hugging Face. Self-hosting on EU infrastructure sidesteps the GDPR data transfer problem of the hosted API (servers in China, no SCCs published). Point of attention: the final licence terms were not yet published at launch (26 July), Kimi K2 carried commercial restrictions above a certain usage scale. Verify the licence before production use. Infrastructure requirement: approx. 1.4 TB of storage, 350–400 GB of GPU memory with MXFP4 quantisation. source

16 July 2026Kimi K3: no opt-out for model training, data processed in China

At the launch of Kimi K3 (16 July 2026), Moonshot AI's privacy policy states that user content may be used for model training and optimisation, with no in-product opt-out. API calls via platform.moonshot.ai are processed on servers in China; an adequacy decision or SCCs are not explicitly documented. For EU organisations: do not enter personal data until Moonshot publishes a GDPR-compliant set-up. Self-hosting on EU infrastructure (open weights available from around 27 July 2026) avoids the transfer problem. source

Questions

How safe is Kimi for pharmacy & pharmaceuticals?
Kimi has a concrete GDPR concern. The parent company is based in Beijing and falls under Chinese security legislation; the privacy policy does not explicitly name that jurisdiction. Keep confidential data out of the consumer app; self-hosting the open weights is the safe route. Weigh this heavily before you deploy it in pharmacy & pharmaceuticals. There is a concrete GDPR concern, read the details on the page.
Does Kimi train on my data?
The international service is provided by Moonshot AI Pte. Ltd. (Singapore); according to the privacy policy, data is stored on servers in Singapore and content may be used to improve the service. The K2 models are open-weight and can be self-hosted.
What should I look out for with AI in pharmacy & pharmaceuticals?
Medication data is special category personal data under the GDPR. Only use systems with a data processing agreement and EU hosting; do not store audio recordings of pharmaceutical consultations unencrypted on external servers. AI-supported medication reviews and interaction checks are supportive only: the pharmacist remains ultimately responsible for pharmaceutical care and must never rely blindly on algorithmic outcomes.

Source documents

Everything about Kimi Best AI for pharmacy & pharmaceuticals

Summarised by the editorial team from provider documentation · not legal advice

Last checked: 1 November 2026 · How we check

Every Friday: what changed in AI for pharmacy & pharmaceuticals

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.